Physician profile
Thom R Loree
NPI 1215927330
$6,817.49
in general payments reported to CMS, 2019-2025
15 companies · $422 in 2025
The $422 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,936 · 2020: $1,600 · 2021: $240 · 2022: $198 · 2023: $698 · 2024: $723 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,843.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $3,120.00 | 2019-2021 | |
| Inspire Medical Systems, INC. | $1,666.27 | 2019-2025 | Inspire |
| Tela Bio, INC. | $432.85 | 2019-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $295.96 | 2023-2024 | Irrisept |
| Integra Lifesciences Corporation | $248.67 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Abbott Laboratories | $221.31 | 2024 | Proclaim |
| Axogen | $149.99 | 2023 | Avance Nerve Graft |
| Kerecis Limited | $146.82 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $136.91 | 2025 | |
| Smith+Nephew, INC. | $135.98 | 2023 | Grafix Pl |
| Intuitive Surgical, INC. | $124.99 | 2025 | |
| Kci USA, INC. | $75.66 | 2022 | |
| Polynovo North America LLC | $48.67 | 2024-2025 | Novosorb Btm |
| Baxter Healthcare | $13.41 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thom Loree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.